⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

SRPT

Sarepta Therapeutics, Inc.

Healthcare · Biotechnology

17.73USD

-0.4500 (-2.48%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Computing valuation metrics…

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on SRPT.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Valuation

P/E (TTM)

—

P/E (Forward)

7.24x

EV/EBITDA

—

EV/Revenue

1.46x

P/S (TTM)

1.27x

P/B

1.23x

FCF Yield

4.37%

Dividend Yield

0.00%

Gross Margin

69.60%

Operating Margin

-9.73%

Net Margin

-9.29%

Peer Comparison — Biotechnology

CompanyMkt CapP/EEV/EBITDAFCF YieldRev GrowthDiv Yield
SRPTSarepta Therapeutics, Inc.$1.87B——4.37%-35.94%0.00%
VRTXVertex Pharmaceuticals Incorporated$132.71B30.51x24.88x1.98%12.50%0.00%

Subject metrics from SEC filings where available; peer metrics from cached market data.

REGNRegeneron Pharmaceuticals, Inc.
$82.88B
19.91x
15.97x
3.70%
16.70%
0.47%
MRNAModerna, Inc.$79.89B——0.37%2.10%0.00%
ARGXargenx SE$54.94B30.26x715.84x—52.10%0.00%
RPRXRoyalty Pharma plc$36.90B33.97x25.37x-3.24%16.50%1.47%
ROIVRoivant Sciences Ltd.$26.36B——-4.24%-33.50%0.00%
INCYIncyte Corporation$23.45B14.74x9.76x5.03%37.70%0.00%
BNTXBioNTech SE$22.13B——-1.13%-59.50%0.00%